Collaborative Arrangements (Tables)

9 Months Ended

Sep. 30, 2011

Collaborative Arrangements

Collaborative Arrangements

		Three Months Ended September 30,					Nine Months Ended September 30,
		2011			2010		2011			2010
		(in thousands)
Amortized portion of up-front payment		$	3,107		$	3,107	$	9,321		$	9,321
Milestone revenues			200,000			—		250,000			—
Net reimbursement (payment) for telaprevir development costs			(2,557	)		1,148		(6,810	)		7,055
Reimbursement for manufacturing services			7,170			311		20,383			6,536
	Total collaborative revenues attributable to the Janssen collaboration	$	207,720		$	4,566	$	272,894		$	22,912

		Three Months Ended September 30,				Nine Months Ended September 30,
		2011		2010		2011		2010
		(in thousands)
Amortized portion of up-front payments		$	9,558	$	9,558	$	28,674	$	28,674
Development milestone revenues			1,758		—		3,152		—
Payments for manufacturing services			8,184		1,498		14,032		3,976
	Total collaborative revenues attributable to the Mitsubishi Tanabe collaboration	$	19,500	$	11,056	$	45,858	$	32,650

Summary of fair values of consideration paid or payable by the Company pursuant to the Alios Agreement

		As of June 13, 2011
		(in thousands)
Up-front payment		$	60,000
Fair value of contingent milestone and royalty payments			197,720
	Total	$	257,720

Summary of the fair values of the assets and liabilities recorded on the effective date of the Alios Collaboration

		Fair Values as of June 13, 2011
		(in thousands)
Intangible assets		$	250,600
Goodwill			7,399
Deferred tax liability			(89,155	)
Net other assets (liabilities)			(279	)
	Net assets attributable to noncontrolling interest (Alios)	$	168,565

Summary of activity related to net loss attributable to noncontrolling interest of Alios Collaboration

	Three Months Ended September 30, 2011			Nine Months Ended September 30, 2011
	(in thousands)
Income (loss) before provision for income taxes	$	(5,258	)	$	(6,059	)
Provision for income taxes		(4,850	)		(29,298	)
Change in fair value of contingent milestone and royalty payments		17,450			17,450
Net income (loss) attributable to noncontrolling interest (Alios)	$	7,342		$	(17,907	)

Summary of Alios' items included in the Company's condensed consolidated balance sheets

	As of June 13, 2011		As of September 30, 2011
	(in thousands)
Restricted cash and cash equivalents (Alios)	$	4,575	$	50,580
Accounts receivable, net		—		25
Prepaid expenses and other current assets		69		597
Property and equipment, net		885		1,645
Intangible assets		250,600		250,600
Goodwill		7,399		7,399
Other assets		76		133
Accounts payable		1,189		1,905
Accrued expenses and other current liabilities		1,504		1,186
Income taxes payable (Alios)		—		9,755
Deferred tax liability		89,155		103,598
Other liabilities		3,191		3,206
Redeemable noncontrolling interest (Alios)		36,299		36,696
Noncontrolling interest (Alios)		132,266		114,388